Director at Jupiter Neurosciences (JUNS) receives 100K stock options grant

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. director Brady Allison W received a grant of stock options covering 100,000 shares of common stock. The options have an exercise price of $0.2783 per share and expire on June 2, 2036.

The grant was made under the company’s 2025 Equity Incentive Plan. The options vest over three years starting September 2, 2026, in equal quarterly installments, and require continued service through each vesting date. Following this award, the filing shows 100,000 derivative securities held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Brady Allison W

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	100,000	$0.00	--

Holdings After Transaction: Stock Option — 100,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 100,000 options Exercise price: $0.2783 per share Expiration date: June 2, 2036 +2 more

5 metrics

Stock options granted 100,000 options Grant to director on June 2, 2026

Exercise price $0.2783 per share Strike price for granted options

Expiration date June 2, 2036 Option term end date

Post-grant derivative holdings 100,000 options Total options held following transaction

Vesting period Three years, quarterly Vesting from September 2, 2026 in equal installments

Key Terms

2025 Equity Incentive Plan, Stock Option, exercise price, vest over three years

4 terms

2025 Equity Incentive Plan financial

"The options were granted under the Issuer's 2025 Equity Incentive Plan."

Stock Option financial

"security_title: Stock Option with underlying common stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price: 0.2783 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest over three years financial

"The options vest over three years commencing from September 2, 2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brady Allison W

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.2783	06/02/2026		A		100,000		(1)	06/02/2036	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.

	/s/ Allison W. Brady	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Jupiter Neurosciences (JUNS) disclose about Brady Allison W on this Form 4?

Jupiter Neurosciences reported that director Brady Allison W received a grant of 100,000 stock options. These options relate to the company’s common stock and are part of an equity incentive award rather than an open-market purchase or sale.

How many Jupiter Neurosciences (JUNS) options were granted to the director?

The Form 4 shows a grant of 100,000 stock options to director Brady Allison W. Each option is tied to one share of common stock, providing potential future ownership if the options are exercised according to their terms.

What is the exercise price and term of the Jupiter Neurosciences (JUNS) options?

The granted options have an exercise price of $0.2783 per share and expire on June 2, 2036. This means the director can buy shares at $0.2783, if vested, any time before the June 2, 2036 expiration date.

How do the Jupiter Neurosciences (JUNS) options for Brady Allison W vest?

The options vest over three years starting September 2, 2026, in equal quarterly installments. Vesting requires continued service to the company through each vesting date, meaning unvested portions are tied to ongoing board service.

Under which plan were Jupiter Neurosciences (JUNS) options granted to the director?

The options were granted under Jupiter Neurosciences’ 2025 Equity Incentive Plan. This plan is designed to provide equity-based compensation, such as stock options, to eligible participants including directors, aligning their interests with shareholders.

How many derivative securities does Brady Allison W hold after this Jupiter Neurosciences (JUNS) grant?

After the reported transaction, the filing shows Brady Allison W holding 100,000 derivative securities in the form of stock options. These options are held directly and represent potential future ownership of common shares upon exercise.